How can probiotics boost GLP-1 levels naturally?
Glucagon-like peptide-1 (GLP-1) is an incretin hormone produced by intestinal L-cells in response to nutrient intake. Its primary functions include stimulating insulin secretion, inhibiting glucagon release, delaying gastric emptying, and promoting satiety through central nervous system signaling. Recent research highlights the gut microbiome as a central player in modulating GLP-1 production, with specific probiotic strains emerging as key facilitators of this process.
Medications like semaglutide (marketed as Ozempic and Wegovy) mimic GLP-1 activity, yet natural methods to raise natural GLP-1—particularly through probiotics—have gained traction in recent years. Below, we will review how probiotics might boost GLP-1 levels naturally.
Can probiotics increase GLP-1 levels?
It is thought that probiotics can enhance GLP-1 levels through three primary pathways:
- Metabolite production: Probiotics ferment dietary fibers to produce short-chain fatty acids, which stimulate GLP-1 release from intestinal cells.
- Tryptophan metabolism: Certain probiotics, such as Bifidobacterium strains, metabolize dietary tryptophan into indole derivatives, which activate aryl hydrocarbon receptors (AhR) on enteroendocrine cells. This interaction upregulates proglucagon gene expression, the precursor to GLP-1.
- Bile acid deconjugation: Probiotics break down bile acids into secondary forms, such as deoxycholic acid, which attach to Takeda G protein-coupled receptor 5 (TGR5) in the gut. TGR5 activation stimulates GLP-1 release.
Related questions
- Ozempic Side Effects to Watch For
- Wegovy vs Ozempic: Which is Right for You?
- Which GLP-1 drug is best for weight loss?
Which probiotics can boost GLP-1 levels?
More research is needed to understand which probiotics can boost GLP-1 levels, and at what amounts. Certain strains have been associated with an increase in short-chain fatty acids and GLP-1 levels in studies. These include strains from Bifidobacterium species, Lactobacillus species, and Akkermansia muciniphila.
- A 2013 study in mice showed that a probiotic containing Lactobacillus acidophilus, Lactobacillus bulgaricus, Lactobacillus casei, Lactobacillus plantarum, Bifidobacteriium brevis, Bifidobacteriium infantis, Bifidobacteriium longum, and Streptococcus salivarius ssp thermophilus promoted the release of GLP-1.
- A small 2015 study showed that patients taking Lactobacillus reuteri daily for 4 weeks had 76% higher GLP-1 release compared to placebo.
- In a small 2021 study of patients with diabetes, those taking combined Bifidobacterium, Lactobacillus, Enterococcus and Bacillus cereus tablets showed a change in intestinal short-chain fatty acids compared to the control group. GLP-1 levels were not measured, but metabolic changes such as reductions in blood sugar were seen in patients taking probiotics.
- In a 2022 study, patients with gestational diabetes taking Sutterella, Oscillibacter, and Bifidobacterium had an increase in GLP-1 levels.
Probiotics should not be used to replace antidiabetes treatments recommended by your healthcare provider. More research is needed to understand the safety and effectiveness of using probiotics to boost GLP-1 levels and lower blood sugar.
References
Cani, P. D., et. al. 2021. A newly identified protein from Akkermansia muciniphila stimulates GLP-1 secretion. Cell Metabolism. DOI: https://doi.org/10.1016/j.cmet.2021.05.004
Chimerel, C., et. al. 2014. Bacterial Metabolite Indole Modulates Incretin Secretion from Intestinal Enteroendocrine L Cells. In: Cell Reports. DOI: https://doi.org/10.1016/j.celrep.2014.10.032
Kassaian, N., et. al. 2018. The effects of probiotics and synbiotic supplementation on glucose and insulin metabolism in adults with prediabetes: a double-blind randomized clinical trial. In: Acta Diabetologica. DOI: https://doi.org/10.1007/s00592-018-1175-2
Li, Y., et. al. 2022. The effects of probiotic administration on patients with prediabetes: a meta-analysis and systematic review. In: Journal of Translational Medicine. DOI: https://doi.org/10.1186/s12967-022-03695-y
Liang, Y., et. al. 2022. Correlation between gut microbiota and glucagon-like peptide-1 in patients with gestational diabetes mellitus. In: World Journal of Diabetes. DOI: https://doi.org/10.4239/wjd.v13.i10.861
Liu, W., et. al. 2024. Multispecies probiotics complex improves bile acids and gut microbiota metabolism status in an in vitro fermentation model. In: Frontiers in Microbiology. DOI: https://doi.org/10.3389/fmicb.2024.1314528
Min, Q., et. al. 2022. Analysis of Intestinal Short-Chain Fatty Acid Metabolism Profile After Probiotics and GLP-1 Treatment for Type 2 Diabetes Mellitus. In: Frontiers in Endocrinology. DOI: https://doi.org/10.3389/fendo.2022.892127
Natividad, J. M., et. al. 2018. Impaired Aryl Hydrocarbon Receptor Ligand Production by the Gut Microbiota Is a Key Factor in Metabolic Syndrome. In: Cell Metabolism. DOI: https://doi.org/10.1016/j.cmet.2018.07.001
Sakurai, T., et. al. 2019. Production of Indole-3-Lactic Acid by Bifidobacterium Strains Isolated fromHuman Infants. In: Microorganisms. DOI: https://doi.org/10.3390/microorganisms7090340
Stenman, L. K., et. al. 2015. Probiotic B420 and prebiotic polydextrose improve efficacy of antidiabetic drugs in mice. In: Diabetology and Metabolic Syndrome. DOI: https://doi.org/10.1186/s13098-015-0075-7
Tassoni, D. S., et. al. 2023. Gut Microbiota and Obesity: The Chicken or the Egg? In: Obestities. DOI: https://doi.org/10.3390/obesities3040024
Thomas, C., et. al. 2010. TGR5-mediated bile acid sensing controls glucose homeostasis. In: Cell Metabolism. DOI: https://doi.org/10.1016/j.cmet.2009.08.001
Wang, Q., et. al. 2023. Gut microbiota regulates postprandial GLP-1 response via ileal bile acid-TGR5 signaling. In: Gut Microbes. DOI: https://doi.org/10.1080/19490976.2023.2274124
Whalley, N. M., et. al. 2011. Processing of proglucagon to GLP-1 in pancreatic α-cells: is this a paracrine mechanism enabling GLP-1 to act on β-cells? In: Journal of Endocrinology. DOI: https://doi.org/10.1530/joe-11-0094
Yadav, H., et. al. 2013. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. In: Journal of Biological Chemistry. DOI: https://doi.org/10.1074/jbc.m113.452516
Zeng, Y., et. al. 2023. Crosstalk between glucagon-like peptide 1 and gut microbiota in metabolic diseases. In: mBio. DOI: https://doi.org/10.1128/mbio.02032-23
Read next
Tirzepatide vs semaglutide: How do they compare?
Both tirzepatide and semaglutide are prescription medicines used with diet and exercise to treat people with type 2 diabetes or to help people lose and maintain weight loss. Tirzepatide is also approved by the FDA to treat moderate to severe obstructive sleep apnea (OSA) in adults with obesity, while semaglutide is approved to reduce the risk of serious heart problems and to help reduce the risk of worsening kidney disease.
Continue reading
Can you get tirzepatide from a compounding pharmacy?
Tirzepatide cannot be legally compounded in a U.S. pharmacy at this time. It has been removed from the FDA drug shortage list as of October 2, 2024. When drugs are in short supply, the FDA may allow temporary compounding of some medicines to allow patients to continue to access their treatments. Tirzepatide is now widely available as a prescription medicine made by Eli Lilly under the brands names Mounjaro (for type 2 diabetes) and Zepbound (for weight loss and sleep apnea).
Continue reading
Why am I not losing weight on Ozempic?
Although Ozempic is not FDA-approved for weight loss, over 86% of people lose at least 5% of their body weight in trials that have studied semaglutide, the active ingredient of Ozempic. But the same clinical trials also show that just under 14% don’t lose weight, and some may even gain weight. Continue reading
See also:
Related medical questions
- Does Ozempic cause muscle loss and how to prevent it?
- How much does semaglutide cost?
- Where and how should Ozempic be injected?
- How does semaglutide work for weight loss?
- Ozempic Face: What causes it and how to prevent it?
- Liraglutide vs Semaglutide: How do they compare?
- What foods should I eat or avoid when taking Rybelsus?
- How does Ozempic affect blood pressure?
- How much weight can you lose with Rybelsus?
- Trulicity vs Ozempic: Which is right for you?
- Why does Ozempic cause a dry mouth or taste changes?
- How long does it take for Rybelsus to start working?
- Can I drink alcohol on Ozempic?
- Does Wegovy make you pee a lot or urine smell?
- Can semaglutide and other GLP-1s cause vision loss?
- How does Wegovy work for weight loss?
- What is compounded semaglutide and is it safe?
- What is the mechanism of action for Rybelsus?
- Can Wegovy or Ozempic be used for heart failure?
- Semaglutide and liraglutide for alcohol use disorder (AUD)
- Wegovy coupon card: Do I qualify and how much can I save?
- What is Rybelsus used for and how does it work?
- What's the buzz on Ozempic and Wegovy?
- Mounjaro vs Ozempic: Which is right for you?
- What are the long-term side effects of Ozempic?
- Ozempic Mounjaro Wegovy & Zepbound: Weight Loss Compared
- How long does it take for Ozempic to work?
- How many doses are in an Ozempic pen?
- Do Ozempic, Wegovy, Mounjaro & Zepbound cause hair loss?
- How does Ozempic work for weight loss?
Drug information
Related support groups
- Semaglutide (38 questions, 53 members)
- Ozempic (115 questions, 229 members)
- Wegovy (50 questions, 115 members)